诺贝尔获奖者演讲(英文)（PPT） .ppt

,fromeinsteintonanotechnology,baotou,april26,2011,themagicandbeautyof(nano-)small,or,workingataneversmallerscaleshapedthe,technicalrevolutionsofthepast,technicalrevolutionswhen,andbywhom”,sequenceofthinking,whatwouldchangeificoulddoit?whatisimportantthatidoit?,howcanidoit?,issuesandchallenges,nanoscalematerialsciencelocalgrowth,nano-particles,nanofornano,thecentralchallengeofnanoscalematerialscience:,growthrcontact1kq10j,(v100mv)nsi100naq10pj,(v100v),fluctuationofcurrents:1/n3%n1000electrons,fluctuationofdopants:1/n3%n1000dopants,thepositionsofthedopantsbecomeimpportant:ordereddopingatoms,dopinglevel:1020cm-3,volume:30 x30 x30nm3,controlbycounting,nanosmallultrahigh,densities:components,energy,intensities:currents,fluxes,fields,speed:mechanics,rates,sensitivity:molecularrecognition,largesystems:ultralargenumbersofcomponents,nanosmall:smallnumbers,nanoscalematerialsciencelocalgrowth,nano-particles,thesolidliquidinterfaceambient,nature,electrochemistry,nano-interfaceinterfaceasactivecomponent,theenergydissipationissuewehavebeentherebefore,the1/nissuesmalln,issuesandchallenges,thepowerproblem:wevebeenherebefore!,steamiron,thecrucialissueofpowerdissipation,numberofcomponents:d-2leadresistance:d-2“contact”resistancerq:d-4leakagecurrents:exp(d),powerdissipationinpresentcmostechnology:50%byactivecomponents,50%byleakagecurrents,off“-statedissipatessameormorethanon“-state,nonvolatileswitches,bistablenanostructures,basedon,formemoriesandprocessors,revivaloftwoterminaldevices,doesnotdowngradeanamplifiertoaswitch,nanoscalematerialsciencelocalgrowth,nano-particles,energysupplyandinformationtransferlocalchemicalenergy,fields,thesolidliquidinterfaceambient,nature,electrochemistry,nano-interfaceinterfaceasactivecomponent,theenergydissipationissuewehavebeentherebefore,the1/nissuesmalln,issuesandchallenges,wirelesscommunicationbetweenmorecomplexlevel,targeteddrugdelivery(drugencapsulaintargetingsystem,0,20,40,60,80,0.001,0.01,0.1,1,10,100,finaldrugconcentrationmol/l,diseasesuppressorefficacy,freedrug,targeted,drug,b),100 xenhanceddrugefficacy,100%,drugefficacy(lowerisbetter),nanocarrier-targeteddrugstrongenhancementondeseasedtargetedcell,brozmorecomplexlevel,targeteddrugdelivery(drugencapsulaintargetingsystem,miniaturizeddiagnostictestsfast,patient-,environmentalandcostfriendlyparalellmultipletests,personalizedmedicine,beatlffler,maclinamceooftheeuropeanfoundationforclinicalnanomedicinealemannengasse12,p.o.boxch-4016basel,switzerlan